Sign In
Buy ETON
$46.42
-2.61 (-5.32%)
At Close: Jul 31, 2026
Eton Pharmaceuticals (ETON) Soars 6.7%: Is Further Upside Left in the Stock?
10:16am, Tuesday, 24'th Mar 2026
Eton Pharmaceuticals (ETON) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price
Recent Price Trend in Eton Pharmaceuticals (ETON) is Your Friend, Here's Why
09:55am, Monday, 23'rd Mar 2026
Eton Pharmaceuticals (ETON) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.
Does Eton Pharmaceuticals (ETON) Have the Potential to Rally 49.25% as Wall Street Analysts Expect?
10:55am, Friday, 20'th Mar 2026
The mean of analysts' price targets for Eton Pharmaceuticals (ETON) points to a 49.3% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement a
Eton Pharmaceuticals, Inc. (ETON) Q4 2025 Earnings Call Transcript
06:42pm, Thursday, 19'th Mar 2026
Eton Pharmaceuticals, Inc. (ETON) Q4 2025 Earnings Call Transcript
Eton Pharmaceuticals, Inc. (ETON) Q4 Earnings Lag Estimates
06:30pm, Thursday, 19'th Mar 2026
Eton Pharmaceuticals, Inc. (ETON) came out with quarterly earnings of $0.05 per share, missing the Zacks Consensus Estimate of $0.12 per share. This compares to a loss of $0.02 per share a year ago.
Eton Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results
04:05pm, Thursday, 19'th Mar 2026
DEER PARK, Ill., March 19, 2026 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (“Eton” or “the Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercia
Eton Pharmaceuticals to Report Fourth Quarter and Full Year 2025 Financial Results on Thursday, March 19, 2026
04:30pm, Tuesday, 03'rd Mar 2026
DEER PARK, Ill., March 03, 2026 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (“Eton” or the “Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercia
DEER PARK, Ill., March 02, 2026 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (“Eton” or “the Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercia
US FDA approves Eton Pharma's hormonal disorder drug
01:51pm, Wednesday, 25'th Feb 2026
The U.S. Food and Drug Administration approved on Wednesday Eton Pharmaceuticals' oral liquid therapy for a rare childhood hormonal disorder, giving families an easier way to manage the condition and
Eton Pharmaceuticals Announces U.S. FDA Approval for DESMODA™ (desmopressin acetate) Oral Solution
01:47pm, Wednesday, 25'th Feb 2026
DEER PARK, Ill., Feb. 25, 2026 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (“Eton” or “the Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercial
Eton Pharmaceuticals to Participate at Leerink Partners Global Healthcare Conference on Wednesday, March 11th
06:50am, Friday, 20'th Feb 2026
DEER PARK, Ill., Feb. 20, 2026 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (“Eton” or the “Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercial
Eton Pharmaceuticals Announces Licensing of Rare Disease Product Candidate
06:50am, Monday, 02'nd Feb 2026
DEER PARK, Ill., Feb. 02, 2026 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (“Eton” or “the Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercial
Eton Pharmaceuticals: An Undervalued Small Cap With High Growth
10:20am, Friday, 23'rd Jan 2026
Eton offers a diversified, acquisition-driven portfolio in ultra-rare pediatric endocrinology and metabolic diseases, targeting significant peak sales potential. My DCF-based Fair Value is $28.1, repr
Eton Pharmaceuticals to Present at Piper Sandler 37th Annual Healthcare Conference on December 4th
04:30pm, Monday, 24'th Nov 2025
DEER PARK, Ill., Nov. 24, 2025 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (“Eton” or the “Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercial
Acadian Asset Management LLC Sells 9,713 Shares of Eton Pharmaceuticals, Inc. $ETON
03:14am, Friday, 14'th Nov 2025
Acadian Asset Management LLC decreased its position in shares of Eton Pharmaceuticals, Inc. (NASDAQ: ETON) by 2.4% during the second quarter, according to its most recent filing with the Securities an
